251 related articles for article (PubMed ID: 30641296)
1. Cancer Stem Cell based molecular predictors of tumor recurrence in Oral squamous cell carcinoma.
Mohanta S; Sekhar Khora S; Suresh A
Arch Oral Biol; 2019 Mar; 99():92-106. PubMed ID: 30641296
[TBL] [Abstract][Full Text] [Related]
2. ZEB1 as an indicator of tumor recurrence for areca quid chewing-associated oral squamous cell carcinomas.
Ho CM; Hu FW; Lee SS; Shieh TM; Yu CH; Lin SS; Yu CC
J Oral Pathol Med; 2015 Oct; 44(9):693-8. PubMed ID: 25367287
[TBL] [Abstract][Full Text] [Related]
3. Silencing JARID1B suppresses oncogenicity, stemness and increases radiation sensitivity in human oral carcinoma.
Lin CS; Lin YC; Adebayo BO; Wu A; Chen JH; Peng YJ; Cheng MF; Lee WH; Hsiao M; Chao TY; Yeh CT
Cancer Lett; 2015 Nov; 368(1):36-45. PubMed ID: 26184998
[TBL] [Abstract][Full Text] [Related]
4. Tumor-related markers in histologically normal margins correlate with locally recurrent oral squamous cell carcinoma: a retrospective study.
Wang X; Chen S; Chen X; Zhang C; Liang X
J Oral Pathol Med; 2016 Feb; 45(2):83-8. PubMed ID: 26260282
[TBL] [Abstract][Full Text] [Related]
5. Strong correlation between c-erbB-2 overexpression and overall survival of patients with oral squamous cell carcinoma.
Xia W; Lau YK; Zhang HZ; Liu AR; Li L; Kiyokawa N; Clayman GL; Katz RL; Hung MC
Clin Cancer Res; 1997 Jan; 3(1):3-9. PubMed ID: 9815530
[TBL] [Abstract][Full Text] [Related]
6. miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling.
Lu M; Wang C; Chen W; Mao C; Wang J
DNA Cell Biol; 2018 Apr; 37(4):381-388. PubMed ID: 29364705
[TBL] [Abstract][Full Text] [Related]
7. UBE2C promotes the progression of head and neck squamous cell carcinoma.
Jin Z; Zhao X; Cui L; Xu X; Zhao Y; Younai F; Messadi D; Hu S
Biochem Biophys Res Commun; 2020 Mar; 523(2):389-397. PubMed ID: 31870550
[TBL] [Abstract][Full Text] [Related]
8. Correlation of gene methylation in surgical margin imprints with locoregional recurrence in head and neck squamous cell carcinoma.
Hayashi M; Wu G; Roh JL; Chang X; Li X; Ahn J; Goldsmith M; Khan Z; Bishop J; Zhang Z; Zhou XC; Richmon J; Agrawal N; Koch WM
Cancer; 2015 Jun; 121(12):1957-65. PubMed ID: 25773145
[TBL] [Abstract][Full Text] [Related]
9. Her2 expression and gene amplification is rarely detectable in patients with oral squamous cell carcinomas.
Hanken H; Gaudin R; Gröbe A; Fraederich M; Eichhorn W; Smeets R; Simon R; Sauter G; Grupp K; Izbicki JR; Sehner S; Heiland M; Blessmann M
J Oral Pathol Med; 2014 Apr; 43(4):304-8. PubMed ID: 24645976
[TBL] [Abstract][Full Text] [Related]
10.
Imai A; Mochizuki D; Misawa Y; Nakagawa T; Endo S; Mima M; Yamada S; Kawasaki H; Kanazawa T; Misawa K
DNA Cell Biol; 2019 Jul; 38(7):678-687. PubMed ID: 31188017
[TBL] [Abstract][Full Text] [Related]
11. Tumor Budding, EMT and Cancer Stem Cells in T1-2/N0 Oral Squamous Cell Carcinomas.
Attramadal CG; Kumar S; Boysen ME; Dhakal HP; Nesland JM; Bryne M
Anticancer Res; 2015 Nov; 35(11):6111-20. PubMed ID: 26504037
[TBL] [Abstract][Full Text] [Related]
12. Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma.
Lv Z; Wu X; Cao W; Shen Z; Wang L; Xie F; Zhang J; Ji T; Yan M; Chen W
J Exp Clin Cancer Res; 2014 Dec; 33(1):100. PubMed ID: 25539663
[TBL] [Abstract][Full Text] [Related]
13. The role of novel prognostic markers PROX1 and FOXC2 in carcinogenesis of oral squamous cell carcinoma.
Agnihotri NS; Astekar M
J Exp Ther Oncol; 2018 May; 12(3):171-184. PubMed ID: 29790306
[TBL] [Abstract][Full Text] [Related]
14. Pokemon proto-oncogene in oral cancer: potential role in the early phase of tumorigenesis.
Sartini D; Lo Muzio L; Morganti S; Pozzi V; Di Ruscio G; Rocchetti R; Rubini C; Santarelli A; Emanuelli M
Oral Dis; 2015 May; 21(4):462-9. PubMed ID: 25439053
[TBL] [Abstract][Full Text] [Related]
15. Molecular profiling of tumour budding implicates TGFβ-mediated epithelial-mesenchymal transition as a therapeutic target in oral squamous cell carcinoma.
Jensen DH; Dabelsteen E; Specht L; Fiehn AM; Therkildsen MH; Jønson L; Vikesaa J; Nielsen FC; von Buchwald C
J Pathol; 2015 Aug; 236(4):505-16. PubMed ID: 25925492
[TBL] [Abstract][Full Text] [Related]
16. Identification of potential core genes and pathways predicting pathogenesis in head and neck squamous cell carcinoma.
Wang M; Zhong B; Li M; Wang Y; Yang H; Du K
Biosci Rep; 2021 May; 41(5):. PubMed ID: 33982750
[TBL] [Abstract][Full Text] [Related]
17. Recurrent CDK1 overexpression in laryngeal squamous cell carcinoma.
Bednarek K; Kiwerska K; Szaumkessel M; Bodnar M; Kostrzewska-Poczekaj M; Marszalek A; Janiszewska J; Bartochowska A; Jackowska J; Wierzbicka M; Grenman R; Szyfter K; Giefing M; Jarmuz-Szymczak M
Tumour Biol; 2016 Aug; 37(8):11115-26. PubMed ID: 26912061
[TBL] [Abstract][Full Text] [Related]
18. Acidic leucine-rich nuclear phosphoprotein-32A (ANP32A) association with lymph node metastasis predicts poor survival in oral squamous cell carcinoma patients.
Velmurugan BK; Yeh KT; Lee CH; Lin SH; Chin MC; Chiang SL; Wang ZH; Hua CH; Tsai MH; Chang JG; Ko YC
Oncotarget; 2016 Mar; 7(10):10879-90. PubMed ID: 26918356
[TBL] [Abstract][Full Text] [Related]
19. Application of Random Forest and data integration identifies three dysregulated genes and enrichment of Central Carbon Metabolism pathway in Oral Cancer.
Mukhopadhyay S; Ghosh S; Das D; Arun P; Roy B; Biswas NK; Maitra A; Majumder PP
BMC Cancer; 2020 Dec; 20(1):1219. PubMed ID: 33317464
[TBL] [Abstract][Full Text] [Related]
20. Enhanced cell migration and apoptosis resistance may underlie the association between high SERPINE1 expression and poor outcome in head and neck carcinoma patients.
Pavón MA; Arroyo-Solera I; Téllez-Gabriel M; León X; Virós D; López M; Gallardo A; Céspedes MV; Casanova I; López-Pousa A; Mangues MA; Quer M; Barnadas A; Mangues R
Oncotarget; 2015 Oct; 6(30):29016-33. PubMed ID: 26359694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
